Akebia Therapeutics (NQ: AKBA )

2.470 USD -0.050 (-1.98%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist

Price and Volume

Volume	2,028,120
Open	2.540
Bid (Size)	2.500 (35)
Ask (Size)	2.520 (100)
Prev. Close	2.520
Today's Range	2.450 - 2.580
52wk Range	2.090 - 12.17
Shares Outstanding	160,115,163
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Akebia Therapeutics to Report Second Quarter 2021 Financial Results and Discuss Recent Business Highlights

July 26, 2021

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akebia Therapeutics, Inc. and Encourages Investors who Formerly Held Shares of Keryx Biopharmaceuticals (KERX) to

July 27, 2021

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akebia Therapeutics, Inc.

Performance

YTD	-15.41%	-15.41%
1 Month	-36.01%	-36.01%
3 Month	-24.00%	-24.00%
6 Month	-27.78%	-27.78%
1 Year	-79.00%	-79.00%

More News

These Penny Stocks Are Frequently Talked About on Reddit, Here’s Why

July 23, 2021

SHAREHOLDER ALERT: Robbins LLP Announces that Akebia Therapeutics, Inc. (AKBA) is Being Sued for Misleading Keryx Biopharmaceuticals, Inc. (KERX) Shareholders Ahead of Merger

July 26, 2021

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 01, 2021

Best 3 Penny Stocks to Watch Right Now, Worth it or Not?

July 14, 2021

Akebia Therapeutics Announces Presentations at ERA-EDTA Virtual Congress 2021

June 03, 2021

Meme Penny Stocks Are Here to Stay; 3 For Your Summer Watchlist

June 08, 2021

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 02, 2021

12 Health Care Stocks Moving In Friday's Pre-Market Session

July 16, 2021

Thinking about buying stock in Ion Geophysical, Moneygram International, Akebia Therapeutics, iBio, or Exela Technologies?

July 16, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.